Tel: 01789 267520

AveXis Issues U.S. Community Statement on BLA Acceptance

12 December 2018

AveXis has provided the following U.S. community statement on the BLA submission and acceptance for their investigational therapy, AVXS-101 - now known as ZOLGENSMATM.

Read the statement